NOVAN INC (NOVN)
US66988N2053 - Common Stock
Novan craters as company files for bankruptcy, to sell most of its assets (NASDAQ:NOVN)
Novan (NOVN) shares plummeted -68.7% on Monday after the company said it had filed for bankruptcy and entered into a deal to sell most of its assets to Ligand Pharmaceuticals (LGND) for...
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio...
Novan drops 13%, will reduce workforce by 50% (NASDAQ:NOVN)
Novan (NOVN) will restructure its commercial business, impacting 39 employees, resulting in a reduction of ~50% of employees, primarily among its field sales representatives.The...
Novan Focuses Strategic Direction and Announces Restructuring
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
– Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% (SB206) – – Strong prescription growth across three promoted...
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
DURHAM, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first...
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
Published results from a National Psoriasis Foundation-fielded survey included responses from more than 400 patients across US1 Findings highlight...
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
Live moderated webcast with members of the Novan management team and dermatological key opinion leader, Dr. Jeffrey Sugarman on Tuesday, April 25th at 2:00 PM ET
Novan rises 12% on full-year result beat (NASDAQ:NOVN)
Novan (NOVN) is trading 12.1% higher after the company posted better-than-expected full-year result helped by strong sales of medical dermatology products. License and...
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
– Berdazimer gel, 10.3% (SB206) assigned PDUFA goal date of January 5, 2024 – – Strong year-over-year prescription growth across three promoted...